These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36424819)

  • 1. Specialized Versus Generic Allied Health Therapy and the Risk of Parkinson's Disease Complications.
    Talebi AH; Ypinga JHL; De Vries NM; Nonnekes J; Munneke M; Bloem BR; Heskes T; Ben-Shlomo Y; Darweesh SKL
    Mov Disord; 2023 Feb; 38(2):223-231. PubMed ID: 36424819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From trials to clinical practice: Temporal trends in the coverage of specialized allied health services for Parkinson's disease.
    Bloem BR; Eimers M; van Galen MS; Munneke M; Darweesh SKL
    Eur J Neurol; 2021 Mar; 28(3):775-782. PubMed ID: 33141474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB).
    Clarke CE; Patel S; Ives N; Rick CE; Woolley R; Wheatley K; Walker MF; Zhu S; Kandiyali R; Yao G; Sackley CM
    Health Technol Assess; 2016 Aug; 20(63):1-96. PubMed ID: 27580669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data.
    Ypinga JHL; de Vries NM; Boonen LHHM; Koolman X; Munneke M; Zwinderman AH; Bloem BR
    Lancet Neurol; 2018 Feb; 17(2):153-161. PubMed ID: 29246470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns and predictors of referrals to allied health services for individuals with Parkinson's disease: A Parkinson's foundation (PF) QII study.
    Roberts AC; Rafferty MR; Wu SS; Miao G; Cubillos F; Simuni T; ;
    Parkinsonism Relat Disord; 2021 Feb; 83():115-122. PubMed ID: 33339716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specialized Allied Health Care for Parkinson's Disease: State of the Art and Future Directions.
    Sturkenboom IHWM; Talebi AH; Maas BR; de Vries NM; Darweesh SKL; Kalf JG
    J Parkinsons Dis; 2024; 14(s1):S193-S207. PubMed ID: 39031380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orthostatic Hypotension: A Prodromal Marker of Parkinson's Disease?
    Dommershuijsen LJ; Heshmatollah A; Mattace Raso FUS; Koudstaal PJ; Ikram MA; Ikram MK
    Mov Disord; 2021 Jan; 36(1):164-170. PubMed ID: 32965064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allied health care in Parkinson's disease: referral, consultation, and professional expertise.
    Nijkrake MJ; Keus SH; Oostendorp RA; Overeem S; Mulleners W; Bloem BR; Munneke M
    Mov Disord; 2009 Jan; 24(2):282-6. PubMed ID: 19170189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002814. PubMed ID: 11406045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stemming the Tide: The Proactive Role of Allied Health Therapy in Parkinson's Disease.
    Rafferty MR; Foster ER; Roberts AC; Smaller KA; Johnson LL; Lawson RA
    J Parkinsons Dis; 2024; 14(s1):S7-S19. PubMed ID: 38848194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Medical Claims Analyses to Understand Interventions for Parkinson Patients.
    Bloem BR; Ypinga JHL; Willis A; Canning CG; Barker RA; Munneke M; De Vries NM
    J Parkinsons Dis; 2018; 8(1):45-58. PubMed ID: 29254108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson's: the PDSAFE RCT.
    Ashburn A; Pickering R; McIntosh E; Hulbert S; Rochester L; Roberts HC; Nieuwboer A; Kunkel D; Goodwin VA; Lamb SE; Ballinger C; Seymour KC
    Health Technol Assess; 2019 Jul; 23(36):1-150. PubMed ID: 31339100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact and feasibility of a brief, virtual, educational intervention for home healthcare professionals on Parkinson's Disease and Related Disorders: pilot study of I SEE PD Home.
    Hess SP; Levin M; Akram F; Woo K; Andersen L; Trenkle K; Brown P; Ouyang B; Fleisher JE
    BMC Med Educ; 2022 Jun; 22(1):506. PubMed ID: 35761252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ParkinsonNet trial: design and baseline characteristics.
    Keus SH; Nijkrake MJ; Borm GF; Kwakkel G; Roos RA; Berendse HW; Adang EM; Overeem S; Bloem BR; Munneke M;
    Mov Disord; 2010 May; 25(7):830-7. PubMed ID: 20461799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Fullard ME; Thibault DP; Hill A; Fox J; Bhatti DE; Burack MA; Dahodwala N; Haberfeld E; Kern DS; Klepitskava OS; Urrea-Mendoza E; Myers P; Nutt J; Rafferty MR; Schwalb JM; Shulman LM; Willis AW;
    Neurology; 2017 Sep; 89(11):1162-1169. PubMed ID: 28835397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of Plasma Infusions in Parkinson's Disease.
    Parker JE; Martinez A; Deutsch GK; Prabhakar V; Lising M; Kapphahn KI; Anidi CM; Neuville R; Coburn M; Shah N; Bronte-Stewart HM
    Mov Disord; 2020 Nov; 35(11):1905-1913. PubMed ID: 32633860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ParkinsonNet concept: development, implementation and initial experience.
    Nijkrake MJ; Keus SH; Overeem S; Oostendorp RA; Vlieland TP; Mulleners W; Hoogerwaard EM; Bloem BR; Munneke M
    Mov Disord; 2010 May; 25(7):823-9. PubMed ID: 20461798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Type 2 Diabetes in Parkinson's Disease.
    Athauda D; Evans J; Wernick A; Virdi G; Choi ML; Lawton M; Vijiaratnam N; Girges C; Ben-Shlomo Y; Ismail K; Morris H; Grosset D; Foltynie T; Gandhi S
    Mov Disord; 2022 Aug; 37(8):1612-1623. PubMed ID: 35699244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiotherapy versus placebo or no intervention in Parkinson's disease.
    Tomlinson CL; Patel S; Meek C; Herd CP; Clarke CE; Stowe R; Shah L; Sackley CM; Deane KH; Wheatley K; Ives N
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD002817. PubMed ID: 24018704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.